Old Web
English
Sign In
Acemap
>
authorDetail
>
V.S. Bogatyrev
V.S. Bogatyrev
Medicine
Internal medicine
Oncology
relapsed refractory
conditioning regimen
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)
2021
Clinical oncohematology
Vladislav Olegovich Sarzhevskii
E. A. Demina
Ne Mochkin
A. A. Spornik
A. A. Mamedova
E. G. Smirnova
Ae Bannikova
A. A. Samoilova
V.S. Bogatyrev
V. Ya. MelNichenko
Show All
Source
Cite
Save
Citations (2)
The use of checkpoint inhibitors in classical hodgkin's lymphoma during the covid-19 pandemic (Pirogov medical center's experience)
2020
Vo Sarzhevskii
E. A. Demina
N.E. Mochkin
A. A. Spornik
A. A. Mamedova
E. G. Smirnova
A. E. Bannikova
A. A. Samoilova
V.S. Bogatyrev
Bronov, O. Yu, Abovich, Yu A.
V. Ya. MelNichenko
Show All
Source
Cite
Save
Citations (0)
Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas
2020
Clinical oncohematology
Vo Sarzhevskii
Anastasiya Aleksandrovna Samoilova
V. Ya. MelNichenko
Yu. N. Dubinina
Ne Mochkin
Ds Kolesnikova
Denis A. Fedorenko
E. G. Smirnova
Ae Bannikova
V.S. Bogatyrev
Show All
Source
Cite
Save
Citations (0)
1